535.80
0.96%
ICICI Securities Limited
Suven’s rapid ascendance in the CDMO space has been remarkable. It has journeyed from being a small molecule-focused CDMO to achieving eminence as one of the few CDMOs in India that offers contract manufacturing of oligonucleotides and ADCs.
Cohance Lifesciences.. has an average target of 984.00 from 2 brokers.
More from Cohance Lifesciences Ltd.
Recommended